| Sample ID . | Cancer type . | Stage . | MKRN3 . | KRAS . |
|---|---|---|---|---|
| nsclc_mskcc_2018s51 | NSCLC | NA | R102Kfs*28 | G13C |
| LUAD-RT-S01777 | Lung adenocarcinoma | IIIB | P362Hfs*34 | G12A |
| TCGA-62-8398-01 | Lung adenocarcinoma | IIIA | S118L | G12D |
| LUAD-NYU408 | Lung adenocarcinoma | IB | A203G | G12V |
| nsclc_mskcc_2018s26 | NSCLC | NA | Q281K | G12C |
| TCGA-78-7166-01 | Lung adenocarcinoma | IIB | W347C | G12C |
| TCGA-O2-A52Q-01 | Lung squamous cell carcinoma | III | R401W | G13C |
| TCGA-64-5775-01 | Lung adenocarcinoma | IIIA | P411Q | Q61L |
| LUAD-S00488 | Lung adenocarcinoma | IIIA | Hom Del | G12C |
| TCGA-44-8117-01 | Lung adenocarcinoma | IB | Hom Del | L19F |
| TCGA-64-1677-01 | Lung adenocarcinoma | IIIA | Hom Del | G12C |
| TCGA-86-7953-01 | Lung adenocarcinoma | IA | Hom Del | G12D |
| TCGA-95-7039-01 | Lung adenocarcinoma | IIB | Hom Del | D33E |
| TCGA-95-A4VP-01 | Lung adenocarcinoma | IIIA | Hom Del | G12V |
| Sample ID . | Cancer type . | Stage . | MKRN3 . | KRAS . |
|---|---|---|---|---|
| nsclc_mskcc_2018s51 | NSCLC | NA | R102Kfs*28 | G13C |
| LUAD-RT-S01777 | Lung adenocarcinoma | IIIB | P362Hfs*34 | G12A |
| TCGA-62-8398-01 | Lung adenocarcinoma | IIIA | S118L | G12D |
| LUAD-NYU408 | Lung adenocarcinoma | IB | A203G | G12V |
| nsclc_mskcc_2018s26 | NSCLC | NA | Q281K | G12C |
| TCGA-78-7166-01 | Lung adenocarcinoma | IIB | W347C | G12C |
| TCGA-O2-A52Q-01 | Lung squamous cell carcinoma | III | R401W | G13C |
| TCGA-64-5775-01 | Lung adenocarcinoma | IIIA | P411Q | Q61L |
| LUAD-S00488 | Lung adenocarcinoma | IIIA | Hom Del | G12C |
| TCGA-44-8117-01 | Lung adenocarcinoma | IB | Hom Del | L19F |
| TCGA-64-1677-01 | Lung adenocarcinoma | IIIA | Hom Del | G12C |
| TCGA-86-7953-01 | Lung adenocarcinoma | IA | Hom Del | G12D |
| TCGA-95-7039-01 | Lung adenocarcinoma | IIB | Hom Del | D33E |
| TCGA-95-A4VP-01 | Lung adenocarcinoma | IIIA | Hom Del | G12V |
The co-occurrence of MKRN3 aberrations with KRAS mutations in human lung cancer datasets. Data from lung cancer patients obtained from TCGA lung cancer studies. Sample IDs as well as the precise mutations identified in these patients are indicated. Hom del, homozygous deletion; NA, not available.